fondaparinux
Showing 1 - 25 of 131
Superficial Vein Thrombosis, Endovenous Laser Ablation Trial in Moscow (Endovenous laser ablation, Fondaparinux Sodium)
Recruiting
- Superficial Vein Thrombosis
- Endovenous Laser Ablation
- Endovenous laser ablation
- Fondaparinux Sodium
-
Moscow, Russian FederationNational Medical Research Center for Therapy and Preventive Medi
Nov 2, 2022
Medical Patient, Thrombocytopenia Trial in Chieti (Fondaparinux)
Terminated
- Medical Patient
- Thrombocytopenia
- Fondaparinux
-
Chieti, ItalyMarcello Di Nisio
Jul 14, 2021
Venous Thrombosis Trial in Bethlehem (Arixtra (Fondaparinox) 2.5 mg SC Daily, Lovenox 40mg SC Daily)
Terminated
- Venous Thrombosis
- Arixtra (Fondaparinox) 2.5 mg SC Daily
- Lovenox 40mg SC Daily
-
Bethlehem, PennsylvaniaLehigh Valley Hospital Muhlenberg
Oct 14, 2021
Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and
Unknown status
- Anticoagulation
- +2 more
- Estimated anticoagulant level (conversion factor x anti-Xa activity)
- (no location specified)
Nov 30, 2020
Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving
Not yet recruiting
- Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis
- Assessment the activity of anti-Xa factor.
-
Gdańsk, Pomorskie, PolandMedical University of Gdansk - Departament of Anesthesiology and
Dec 15, 2020
Thromboembolism in the Puerperium Trial in Cheras (Fondaparinux 2.5Mg/0.5Ml Inj Syr)
Completed
- Thromboembolism in the Puerperium
- Fondaparinux 2.5Mg/0.5Ml Inj Syr
-
Cheras, Kuala Lumpur, MalaysiaDepartment of Obstetrics & Gynaecology, Universiti Kebangsaan Me
Jun 24, 2020
Cancer, Cancer Diagnosis, Thromboembolism Trial in Athens
Unknown status
- Cancer
- +2 more
-
Athens, Attica, GreeceIoannis Karaitianos
Jul 30, 2020
VTE and Higher Hypercoagulability in Patients Recovered in ICU
Completed
- COVID-19 Disease
- Thromboembolism, Venous
- thromboprophylaxis with low-molecular-weight heparin or fondaparinux
-
Padova, ItalyGiuseppe Camporese
Sep 15, 2020
Heparin-Induced Thrombocytopenia Trial in Louisville (fondaparinux, warfarin)
Terminated
- Heparin-Induced Thrombocytopenia
- fondaparinux
- warfarin
-
Louisville, KentuckyUniversity of Louisville Hospital
Oct 24, 2019
Heparin-Induced Thrombocytopenia Trial (fondaparinux, argatroban or lepirudin)
Withdrawn
- Heparin-Induced Thrombocytopenia
- fondaparinux
- argatroban or lepirudin
- (no location specified)
Aug 12, 2019
Pneumonia, Viral, Corona Virus Infection, Respiratory Failure Trial in Milano (Tirofiban Injection, Clopidogrel, Acetylsalicylic
Completed
- Pneumonia, Viral
- +3 more
- Tirofiban Injection
- +3 more
-
Milano, Lombardia, ItalyL. Sacco Hospital
Apr 28, 2020
Deep Venous Thrombosis, Pulmonary Embolism Trial in Baltimore (Enoxaparin, Fondaparinux)
Completed
- Deep Venous Thrombosis
- Pulmonary Embolism
- Enoxaparin
- Fondaparinux
-
Baltimore, MarylandJohns Hopkins Bayview Medical Center
Jun 5, 2019
Thromboprophylaxis Appropriateness in Hospitalized Medical
Recruiting
- Deep Vein Thrombosis
- +2 more
-
Baghdad, IraqEUC
Oct 21, 2022
Venous Thromboembolism, Arterial Thromboembolism Trial in United States (IMPROVE DD VTE Tool)
Completed
- Venous Thromboembolism
- Arterial Thromboembolism
- IMPROVE DD VTE Tool
-
Manhasset, New York
- +4 more
Jul 29, 2022
Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary
Recruiting
- Pulmonary Embolism
- Tissue Plasminogen Activator, Alteplase
- Low-molecular weight heparin
-
İzmir, Bornova/İzmir, TurkeyEge University
Aug 22, 2022
Stroke Trial in Kastamonu (The Effect of Different Pressure Periods on Bruising and Pain After Subcutaneous Heparin Injection
Completed
- Stroke
- The Effect of Different Pressure Periods on Bruising and Pain After Subcutaneous Heparin Injection Applied to the Upper Arm Region
-
Kastamonu, TurkeyKastamonu University
Oct 6, 2023
COVID-19 Trial in Toronto (Therapeutic Anticoagulation)
Completed
- COVID-19
- Therapeutic Anticoagulation
-
Toronto, Ontario, CanadaSt. Michael's Hospital
Oct 22, 2021
COVID, Coronavirus Infection, Severe Acute Respiratory Syndrome Trial in São Paulo (Therapeutic anticoagulation)
Completed
- COVID
- +4 more
- Therapeutic anticoagulation
-
São Paulo, SP, BrazilHospital das Clínicas da FMUSP
Oct 25, 2021
Unstable Angina, Myocardial Infarction Trial in Hamilton (Early Coronary Intervention, Delayed Coronary Intervention)
Completed
- Unstable Angina
- Myocardial Infarction
- Early Coronary Intervention
- Delayed Coronary Intervention
-
Hamilton, Ontario, CanadaHamilton Health Sciences
Apr 19, 2022
Venous Thromboembolism Trial in Asahikawa (15mg DU-176b, 30mg DU-176b, Fondaparinux)
Completed
- Venous Thromboembolism
- 15mg DU-176b
- +2 more
-
Asahikawa, Hokkaido Prefecture, JapanToyooka Chuo Hospital
Feb 8, 2019
Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT) Trial in Worldwide (Edoxaban, Standard of Care)
Completed
- Venous Thromboembolism (VTE)
- +2 more
- Edoxaban
- Standard of Care
-
Tucson, Arizona
- +139 more
Jun 28, 2022
Antiphospholipid Syndrome, Anticoagulant Drugs Trial in Clermont-Ferrand (Lupus anticoagulant testing)
Recruiting
- Antiphospholipid Syndrome
- Anticoagulant Drugs
- Lupus anticoagulant testing
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jun 13, 2022